BioOutsource expands in Scotland; EU carries on with ban of GVK-tied drugs;

> BioOutsource, recently acquired by Sartorius Stedim Biotech, has opened a new facility in its native Scotland to support the development of biosimilars, planning to add 50 jobs in the process. More

> European regulators are standing by their decision to suspend the marketing of more than 700 drugs tied to a data scandal at GVK BioSciences, planning to institute a ban starting Aug. 21. News

Suggested Articles

Dr. Ian Hudson is stepping down after six years in charge of the Medicines and Healthcare products Regulatory Agency next month.

Oncology tests in the U.S. are still failing to adequately represent racial diversity, and more needs to be done to help combat this disparity.

Symphony Health has inked a new deal with Close-Up International aimed at boosting its global data services.